ACORDA THERAPEUTICS, INC.: Acorda First Quarter Update: Webcast/Conference Call Scheduled for May 2, 2018

Acorda Therapeutics, Inc. issued the following announcement on April 11.

Acorda Therapeutics, Inc. (Nasdaq:ACOR) will host a conference call and webcast to report its first quarter 2018 financial results on Wednesday, May 2 at 8:30 a.m. ET.

To participate in the conference call, please dial (833) 236-2756 (domestic) or (647) 689-4181 (international) and reference the access code 2477088. The presentation will be available on the Investors section of

A replay of the call will be available from 11:30 a.m. ET on May 2, 2018 until 11:59 p.m. ET on June 2, 2018. To access the replay, please dial (800) 585-8367 (domestic) or (416) 621-4642 (international); reference code 2477088. The archived webcast will be available in the Investor Relations section of the Acorda website at

About Acorda Therapeutics

Founded in 1995, Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda has a pipeline of novel neurological therapies addressing a range of disorders, including Parkinson’s disease and multiple sclerosis. Acorda markets two FDA-approved therapies, including AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg.

Original source can be found here.

Want to get notified whenever we write about Acorda Therapeutics, Inc. ?
Next time we write about Acorda Therapeutics, Inc., we'll email you a link to the story. You may edit your settings or unsubscribe at any time.
Organizations in this story

Acorda Therapeutics, Inc. 420 Saw Mill River Rd Ardsley, NY 10502